Standout Papers
Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
2010 StandoutScience
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
2008
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
2015 StandoutNobel
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
Risk assessment tools to identify women with increased risk of osteoporotic fracture: Complexity or simplicity? A systematic review
2013
Why Is Late‐Life Disability Declining?
2008
G Protein-coupled Receptor Kinases Phosphorylate LRP6 in the Wnt Pathway
2009 StandoutNobel
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
An integrated map of genetic variation from 1,092 human genomes
2012 StandoutNature
UK clinical guideline for the prevention and treatment of osteoporosis
2017
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
2015
Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity
2016
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
2004
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Vertebral Fractures
2011
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Respiratory Uncoupling in Skeletal Muscle Delays Death and Diminishes Age-Related Disease
2007
Osteoporosis
2006
Benefits and Risks of Bisphosphonate Therapy for Osteoporosis
2012
Early Effects of Raloxifene on Clinical Vertebral Fractures at 12 Months in Postmenopausal Women With Osteoporosis
2002
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Glucose Restriction Extends Caenorhabditis elegans Life Span by Inducing Mitochondrial Respiration and Increasing Oxidative Stress
2007
The genetics of ageing
2010 StandoutNature
Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide
2017
A Practical Genome Scan for Population-Specific Strong Selective Sweeps That Have Reached Fixation
2007
Intrinsic Material Properties of Trabecular Bone by Nanoindentation Testing of Biopsies Taken from Healthy Women Before and After Menopause
2012
An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women
2001
Association of Carotid Intima-Medial Thickness and Indices of Arterial Stiffness With Cardiovascular Disease Outcomes in CKD
2007
Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence
2006
Vitamin D Deficiency
2007 Standout
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
2008
High Dietary Protein Intake and Protein-Related Acid Load on Bone Health
2017
The changing landscape of atherosclerosis
2021 StandoutNature
Reduced Relative Risk of Fractures Among Users of Lithium
2005
Effects of abaloparatide-SC (BA058) on bone histology and histomorphometry: The ACTIVE phase 3 trial
2016
A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism
2002
Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study
2005
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis
2004
Fracture Risk From Psychotropic Medications
2008
Does osteocytic SOST suppression mediate PTH bone anabolism?
2010
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Idiopathic hypercalciuria: Can we prevent stones and protect bones?
2018
Osteoporosis: now and the future
2011 Standout
Hormone Replacement Therapy and Prevention of Nonvertebral Fractures
2001
What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?
2010
Vertebral Fractures and Mortality in Older Women
1999
Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
2000
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
2004
Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation,
2017
Occult Vitamin D Deficiency in Postmenopausal US Women With Acute Hip Fracture
1999
Effects of hormone replacement therapy on clinical fractures and height loss: the heart and estrogen/progestin replacement study (HERS)
2001
Treatment of Postmenopausal Osteoporosis
1998
Skeletal remodeling in health and disease
2007 Standout
Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark
2004
Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
2005
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Gene–environment-wide association studies: emerging approaches
2010
Arterial Ultrasonography and Tonometry as Adjuncts to Cardiovascular Risk Stratification
2007
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
2014
Biomedical applications of bisphosphonates
2013
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age
1998
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
2002
Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures
1999
Use of Osteoporosis Medications after Hospitalization for Hip Fracture: A Cross-national Study
2015
Imminent fracture risk
2017
Clinical Use of Bone Densitometry
2002
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
2008
Short Sleep Duration and Weight Gain: A Systematic Review
2008
Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections
2015
Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
2010
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Effect of four monthly oral vitamin D 3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial
2003
Using Osteoporosis Therapies in Combination
2017
Osteoclast differentiation and activation
2003 StandoutNature
Comparative Analysis of the Radiology of Osteoporotic Vertebral Fractures in Women and Men: Cross-Sectional and Longitudinal Observations from the Canadian Multicentre Osteoporosis Study (CaMos)
2017
Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece
2005
High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study
2006
Epidemiology of Vertebral Fractures
2015
Subclinical Thyroid Disease
2004 Standout
Resolution of Bisphosphonate-Associated Osteonecrosis of the Mandible: Possible Application for Intermittent Low-Dose Parathyroid Hormone [rhPTH(1-34)]
2007
Is Cortical Bone Hip? What determines Cortical Bone Properties?
2007
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Adherence to Bisphosphonate Therapy and Fracture Rates in Osteoporotic Women: Relationship to Vertebral and Nonvertebral Fractures From 2 US Claims Databases
2006
Opposite Bone Remodeling Effects of Teriparatide and Alendronate in Increasing Bone Mass
2005
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Parathyroid hormone signaling through low-density lipoprotein-related protein 6
2008
The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis
2003
The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis
2004
The Hallmarks of Aging
2013 Standout
Effect of calcium or vitamin D supplementation on vascular outcomes: A meta-analysis of randomized controlled trials
2013
The Assessment of Fracture Risk
2010
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
2012
Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases
2008
Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis
2004
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Does Arterial Stiffness Predict Atherosclerotic Coronary Events?
2006
Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial
2009
Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women
1997
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
2017
Quantum Experiments and Graphs: Multiparty States as Coherent Superpositions of Perfect Matchings
2017 StandoutNobel
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms
2009
Extending life span by increasing oxidative stress
2011
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Trabecular Bone Score
2016
Bisphosphonate conjugation for bone specific drug targeting
2018
Subclinical thyroid disease
1996
Denosumab and bisphosphonates: Different mechanisms of action and effects
2010
Gait Speed and Survival in Older Adults
2011 Standout
Differing effects of denosumab and alendronate on cortical and trabecular bone
2013
A systematic review of intervention thresholds based on FRAX
2016
Genome-wide detection and characterization of positive selection in human populations
2007 StandoutNature
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Hormonal regulation of longevity in mammals
2007
Advances in Exercise, Fitness, and Performance Genomics
2010
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Fractures in Patients with Hyperthyroidism and Hypothyroidism: A Nationwide Follow-Up Study in 16,249 Patients
2002
Lipoprotein Profile in Subclinical Hypothyroidism: Response to Levothyroxine Replacement, a Randomized Placebo-Controlled Study
2002
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
2016
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001
Long-Term Trandolapril Treatment Is Associated With Reduced Aortic Stiffness
2007
Predictors of Treatment with Osteoporosis Medications After Recent Fragility Fractures in a Multinational Cohort of Postmenopausal Women
2012
Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women
2004
The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study
1998
Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective
2008
Arterial Stiffness and Cardiovascular Events
2010 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Persistent Increase in Bone Turnover in Graves’ Patients with Subclinical Hyperthyroidism
2000
Prevention of Nonvertebral Fractures by Alendronate
1997
Determinants of Bone Loss from the Femoral Neck in Women of Different Ages
2000
[Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
1999
Falls Predict Fractures Independently of FRAX Probability: A Meta-Analysis of the Osteoporotic Fractures in Men (MrOS) Study
2017
Bone Resorption by Osteoclasts
2000 StandoutScience
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Effect of Thyroxine Therapy on Serum Lipoproteins in Patients with Mild Thyroid Failure: A Quantitative Review of the Literature
2000
Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2007
Hip Fractures Risk in Older Men and Women Associated With DXA-Derived Measures of Thigh Subcutaneous Fat Thickness, Cross-Sectional Muscle Area, and Muscle Density
2015
Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect in Routine Clinical Practice
2016
Prediction of Incident Hip Fracture with the Estimated Femoral Strength by Finite Element Analysis of DXA Scans in the Study of Osteoporotic Fractures
2014
Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial
2008
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
2006 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Proteomic Analysis of a Pleistocene Mammoth Femur Reveals More than One Hundred Ancient Bone Proteins
2011
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
2017
Spermidine in health and disease
2018 StandoutScience
Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta‐Analysis
2016
Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial
1998
Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women
1998
Plasma Fatty Acid Composition as a Predictor of Arterial Stiffness and Mortality
2009
Wave Reflection and Arterial Stiffness in the Prediction of 15-Year All-Cause and Cardiovascular Mortalities
2010
Cross-Sectional Correlates of Increased Aortic Stiffness in the Community
2007
Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice
2009
Relations of Inflammatory Biomarkers and Common Genetic Variants With Arterial Stiffness and Wave Reflection
2008
Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
2010
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Arterial Stiffness and Risk of Coronary Heart Disease and Stroke
2006
Impact of Aortic Stiffness on Cardiovascular Disease in Patients With Chest Pain<xref ref-type="author-notes" rid="fn1"><sup>*</sup></xref><subtitle>Assessment With Direct Intra-Arterial Measurement</subtitle>
2007
BMD at Multiple Sites and Risk of Fracture of Multiple Types: Long-Term Results From the Study of Osteoporotic Fractures
2003
Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
2010
Structural insight into TRPV5 channel function and modulation
2019 StandoutNobel
Effects of Subclinical Thyroid Dysfunction on the Heart
2002
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
2016
Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults
2009 Standout
Prognostic Impact of Aortic Stiffness in High-Risk Type 2 Diabetic Patients
2013
Palaeoproteomic evidence identifies archaic hominins associated with the Châtelperronian at the Grotte du Renne
2016 StandoutNobel
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
Factors and Factorizations of Graphs
2011
Central Pressure More Strongly Relates to Vascular Disease and Outcome Than Does Brachial Pressure
2007
Therapeutic Approaches to Bone Diseases
2000 Science
Thyroid carcinoma
2003 Standout
Postmenopausal Osteoporosis
2016
FEA to Measure Bone Strength: A Review
2016
Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population
2006
Works of Douglas C. Bauer being referenced
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
Laboratory reproducibility of biochemical markers of bone turnover in clinical practice
2009
Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone
2001
Incidence and risk factors for a second hip fracture in elderly women. The Study of Osteoporotic Fractures
2003
Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
2010
Correlates of use of antifracture therapy in older women with low bone mineral density
2006
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
2012
Oral Bisphosphonates and Upper Gastrointestinal Tract Problems: What Is the Evidence?
2002
Effects of Continuing or Stopping Alendronate After 5 Years of Treatment
2006
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data
2009
Hormonal Predictors of Bone Loss in Elderly Women: A Prospective Study
1998
The Association Between Trabecular Bone Score and Lumbar Spine Volumetric BMD Is Attenuated Among Older Men With High Body Mass Index
2016
Short-Term Changes in Bone Turnover Markers and Bone Mineral Density Response to Parathyroid Hormone in Postmenopausal Women with Osteoporosis
2006
Understanding and Communicating the Benefits and Risks of Denosumab, Raloxifene, and Teriparatide for the Treatment of Osteoporosis
2013
Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial
2000
Use of Statins and Fracture
2004
Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long-Term Extension
2004
Calcium Supplements and Fracture Prevention
2013
Official Positions for FRAX® Bone Mineral Density and FRAX® Simplification
2011
Factors Associated with Appendicular Bone Mass in Older Women
1993
Clinical Use of Biochemical Markers of Bone Remodeling: Current Status and Future Directions
2000
Prediction of Incident Major Osteoporotic and Hip Fractures by Trabecular Bone Score (TBS) and Prevalent Radiographic Vertebral Fracture in Older Men
2015
Factors associated with the lumbar spine and proximal femur bone mineral density in older men
2005
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
2010
Continuing Bisphosphonate Treatment for Osteoporosis — For Whom and for How Long?
2012
Daily Activity Energy Expenditure and Mortality Among Older Adults
2006
Association of the ACTN3 Genotype and Physical Functioning With Age in Older Adults
2008
Bone Mass and Breast Cancer Risk in Older Women: Differences by Stage at Diagnosis
2001
Case‐Only Analysis of Treatment–Covariate Interactions in Clinical Trials
2006
Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women
1998
The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies
2010
Serum 25-Hydroxyvitamin D, Parathyroid Hormone, and Mortality in Older Men
2010
Assessing Fracture Risk and Effects of Osteoporosis Drugs: Bone Mineral Density and Beyond
2009
What Proportion of Incident Radiographic Vertebral Fractures in Older Men Is Clinically Diagnosed and Vice Versa: A Prospective Study
2016
Rate and circumstances of clinical vertebral fractures in older men
2007
Bone Mineral Density and Endogenous Hormones and Risk of Breast Cancer in Postmenopausal Women (United States)
2001
Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study
2015
Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS)
2016
National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges
2012
Associations between Low Levels of Serum Estradiol, Bone Density, and Fractures among Elderly Women: The Study of Osteoporotic Fractures1
1998
Metabolic Syndrome and the Risk of Cardiovascular Disease in Older Adults
2006
Prognostic Value of Usual Gait Speed in Well‐Functioning Older People—Results from the Health, Aging and Body Composition Study
2005 Standout
Markers of Atherosclerosis and Inflammation for Prediction of Coronary Heart Disease in Older Adults
2010
Central Nervous System–Active Medications and Risk for Falls in Older Women
2002
Inflammatory Markers and Incident Heart Failure Risk in Older Adults
2010
Thyroid Function and Serum Lipids in Older Women: A Population-based Study
1998
The Association Between Protein Intake by Source and Osteoporotic Fracture in Older Men: A Prospective Cohort Study
2016
Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy
2006
Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study
2003
Intermittent Use of Nitrates Increases Bone Mineral Density: The Study of Osteoporotic Fractures
1998
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
2005
Biochemical Markers of Bone Turnover and Prediction of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures
1999
Race and Sex Effects on the Association Between Muscle Strength, Soft Tissue, and Bone Mineral Density in Healthy Elders: The Health, Aging, and Body Composition Study
2001
Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy
2014
Change in Bone Turnover and Hip, Non-Spine, and Vertebral Fracture in Alendronate-Treated Women: The Fracture Intervention Trial
2004
Low Thyrotropin Levels Are Not Associated with Bone Loss in Older Women: A Prospective Study*
1997
Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
1998
Endogenous Hormones and the Risk of Hip and Vertebral Fractures Among Older Women
1999
Fetuin-A and BMD in Older Persons: The Health Aging and Body Composition (Health ABC) Study
2008
Angiotensin‐Converting Enzyme Inhibitor and Statin Use and Incident Mobility Limitation in Community‐Dwelling Older Adults: The Health, Aging and Body Composition Study
2011
Not every 2-tough graph is Hamiltonian
2000
Dietary Sodium Content, Mortality, and Risk for Cardiovascular Events in Older Adults
2015
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use
2005
Quantitative ultrasound and vertebral fracture in postmenopausal women
1995
Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial
2006
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
2012
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
2016
β-Blocker Use, BMD, and Fractures in the Study of Osteoporotic Fractures
2005
Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer
2014
Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial
2007
Novel methods to evaluate fracture risk models
2011
Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: The health, aging, and body composition study
2009
Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial.
2000
Effects of Continuing or Stopping Alendronate After 5 Years of Treatment. The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized Trial
2007
Lack of Evidence Linking Calcium With or Without Vitamin D Supplementation to Cardiovascular Disease in Generally Healthy Adults: A Clinical Guideline From the National Osteoporosis Foundation and the American Society for Preventive Cardiology
2016
Risk Factors for a First-Incident Radiographic Vertebral Fracture in Women 65 Years of Age: The Study of Osteoporotic Fractures
2005
Broadband Ultrasound Attenuation Predicts Fractures Strongly and Independently of Densitometry in Older Women
1997
Risk Factors for a First-Incident Radiographic Vertebral Fracture in Women ≥65 Years of Age: The Study of Osteoporotic Fractures
2005
Low Thyrotropin Levels Are Not Associated with Bone Loss in Older Women: A Prospective Study
1997
Axial Bone Mass in Older Women
1996
WHO absolute fracture risk models (FRAX): Do clinical risk factors improve fracture prediction in older women without osteoporosis?
2011